79.21

0.35% 0.28

After Hours: 78.77 -0.44 -0.56%

Liquidia Corp (LQDA)

Overview News Price History Option Chain Financials Discussions Forecast

Liquidia Corp stock is traded at $79.21, with a volume of 1.71M. It is up +0.35% in the last 24 hours and up +28.07% over the past month. Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Previous Close:

$78.93

Open:

$79.9

24h Volume:

1.71M

Relative Volume:

0.95

Market Cap:

$7.04B

Revenue:

$288.07M

Net Income/Loss:

$22.31M

P/E Ratio:

559.39

EPS:

0.1416

Net Cash Flow:

$41.15M

1W Performance:

+5.44%

1M Performance:

+28.07%

6M Performance:

+157.85%

1Y Performance:

+549.79%

1-Day Range:

$78.36

$80.98

1-Week Range:

$74.03

$80.98

52-Week Range:

$11.86

$80.98

Liquidia Corp Stock (LQDA) Company Profile

Name

Liquidia Corp

Sector

Healthcare (1100)

Industry

Drug Manufacturers - Specialty & Generic (86)

Phone

919.328.4400

Address

419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC

Employee

216

Twitter

@Liquidia_Inc

Next Earnings Date

2026-08-11

Latest SEC Filings

LQDA's Discussions on Twitter

Compare LQDA vs TAK, HLN, TEVA, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LQDA Liquidia Corp	79.21	7.09B	288.07M	22.31M	41.15M	0.1416
TAK Takeda Pharmaceutical Co Adr	16.89	50.65B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.72	41.09B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	35.29	39.45B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	75.42	30.13B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	547.25	23.00B	3.17B	1.29B	1.01B	27.09

Liquidia Corp Stock (LQDA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-25	Initiated	Wells Fargo	Overweight
Aug-15-25	Resumed	Jefferies	Buy
May-19-25	Downgrade	Oppenheimer	Perform → Underperform
Dec-20-24	Initiated	Wells Fargo	Overweight
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Aug-19-24	Upgrade	Raymond James	Outperform → Strong Buy
Aug-16-24	Initiated	Raymond James	Outperform
Jun-25-24	Initiated	Oppenheimer	Perform
Jan-05-24	Reiterated	Needham	Buy
Sep-19-22	Resumed	Wedbush	Underperform
Sep-01-22	Downgrade	Wedbush	Neutral → Underperform
Jul-22-22	Initiated	Ladenburg Thalmann	Buy
May-31-22	Initiated	BTIG Research	Buy
May-26-22	Initiated	BofA Securities	Buy
Dec-04-20	Initiated	H.C. Wainwright	Buy
Nov-20-20	Downgrade	Wedbush	Outperform → Neutral
Nov-08-18	Resumed	Jefferies	Buy
Sep-05-18	Initiated	Wedbush	Outperform
Aug-20-18	Initiated	Jefferies	Buy
Aug-20-18	Initiated	Needham	Buy

View All

Liquidia Corp Stock (LQDA) Latest News

Jun 30, 2026

Applied Materials To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga

Jun 29, 2026

This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga

Jun 29, 2026

BofA cuts Liquidia stock rating on valuation after strong run By Investing.com - Investing.com South Africa

Jun 29, 2026

BofA cuts Liquidia stock rating on valuation after strong run - Investing.com

Jun 29, 2026

Jun 28, 2026

Liquidia Stock Gains Premarket On Q4 Revenue Beat – Investors Are Betting On YUTREPIA Growth - Stocktwits

Jun 28, 2026

Jun 27, 2026

Liquidia (LQDA) Stock Fair Value Rises After Analysts Rework Legal Risk And Earnings - Yahoo Finance

Jun 27, 2026

Why Liquidia (LQDA) Is Up 10.0% After YUTREPIA Drives Its Shift To Commercial Stage - Yahoo Finance

Jun 27, 2026

Liquidia (LQDA) Reaches Commercial Stage As YUTREPIA Draws Institutional Interest - Yahoo Finance

Jun 27, 2026

Jun 26, 2026

LQDA News | LIQUIDIA CORP (NASDAQ:LQDA) - ChartMill

Jun 26, 2026

Liquidia reports Q1 profit, sales surge 44% sequentially - scanx.trade

Jun 26, 2026

Transcript: Liquidia Q1 2026 Earnings Conference Call - Benzinga

Jun 26, 2026